Breast Screening Debate; Experts Question Merits of Mammogram ProgramRead the full-text online article and more details about Breast Screening Debate; Experts Question Merits of Mammogram Program.News Mail Bundaberg Qld
131 Wickham TerraceBrisbaneQLD4000John Wiley & Sons, LtdMedical Journal of AustraliaMITCHELL, H. (1988). Mammography and Breast Cancer Screening - Reply. MED. J. AUSTRALIA.MITCHELL, H. Mammography and Breast Cancer Screening - Reply. MED. J. Australia, vol.148: (5) p. 265-266, Mar 7,...
Preclinical Imaging Facility, Translational Research Institute, Brisbane, QLD, Australia Kamil A. Sokolowski School of Biomedical Sciences, Faculty of Health and Translational Research Institute, Queensland University of Technology, Brisbane, Australia Erik W. Thompson Centre for Cancer Biology, SA Pathology...
Breast Screening ClinicRoyal Women's HospitalHerstonQLD4029John Wiley & Sons, LtdMedical Journal of AustraliaWard BG, JoyGJ,Ramm LE, Baker CA, McGuckinMA. Compar- ative study of mammography and Mammary Serum Antigen estimation for breast cancer screening. Med 1 Aust 1992; 157:161-4....
QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD, Australia Georgia Chenevix-Trench, Amanda Spurdle, Michael T. Parsons PhD, Amanda B. Spurdle PhD & Georgia Chenevix-Trench PhD The University of Melbourne, Department of Medicine, St Vincent’s...
Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, QLD, 4102, Australia Jodi M. Saunus Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, 3010, Australia Kaylene J. Simpson Sir Peter MacCallum Department of Oncology...
Australia; 10Genetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia; 11New Zealand Familial Gastrointestinal Cancer Registry, Auckland City Hospital, Auckland, New Zealand; 12Department of Colorectal Medicine and Genetics, Royal Melbourne Hospital, Parkville, VIC, Austral...
expression by IHC. The utility of PD-L1 IHC is undermined by the well-characterized geographic and temporal heterogeneity and dynamic expression on tumor or tumor-infiltrating immune cells34. Technical differences, variable expression and variation in screening thresholds for PD-L1 expression across ...
(see Fig.2). Only women of European ancestry were included with 60.9% samples from European countries, 31.1% from the USA, 6.1% from Australia and 1.7% from Israel (Supplementary Tables1–4). The mean age at BC diagnosis for mutation carrier cases in CIMBA was 42.5 years (40.9 forBRCA1...
Epithelial Cancer and Mucosal Biology Laboratory, Mater Medical Research Institute, Mater Health Services, South Brisbane, 4101, Qld, Australia Michael A McGuckin Centro de Biología Molecular "Severo Ochoa", Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco...